

![]() |
Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials |
|
Authors | ||
Published in | Annals of the rheumatic diseases. 2010, vol. 69, no. 10, p. 1756-61 | |
Abstract | Tumour necrosis factor (TNF) blockers are known to increase the risk of serious infections in rheumatoid arthritis. Despite wide use of TNF blockers in ankylosing spondylitis (AS), the infection risk has never been evaluated in this disease. | |
Keywords | Antirheumatic Agents/adverse effects — Humans — Opportunistic Infections/complications/epidemiology — Randomized Controlled Trials as Topic — Risk Assessment/methods — Spondylitis, Ankylosing/complications/drug therapy/epidemiology — Tumor Necrosis Factor-alpha/antagonists & inhibitors | |
Identifiers | PMID: 19640854 | |
Full text | ||
Structures | ||
Research group | Epidémiologie clinique (115) | |
Citation (ISO format) | FOUQUE-AUBERT, Anne et al. Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials. In: Annals of the rheumatic diseases, 2010, vol. 69, n° 10, p. 1756-61. doi: 10.1136/ard.2008.098822 https://archive-ouverte.unige.ch/unige:32564 |